Semaglutide recall Canada: the four generic pen recalls and the exact lots to check

Four notices, published between August 12 and September 25, 2026, cover eleven lot numbers in total. If you take generic semaglutide, the whole job comes down to one comparison: the lot printed on your box against the lots below.

This page lists every affected lot exactly as Health Canada printed it, explains each problem in plain words and says what the notices tell you to do. It does not give dosing advice. Your pharmacist does that.

Semaglutide recall Canada checklist: is your pen affected?

Your pen is affected only if its DIN and its lot number both match a recall notice. Here is how to check in a few minutes.

1. Find the DIN. It is the 8-digit number on the box. Generic Apo-Semaglutide pens carry DIN 02568020 or 02568012. Dr. Reddy’s pens carry DIN 02567806 or 02567814.⁵
2. Find the lot. Look for the word “Lot” on the carton and on the pen label. Copy every character, including any letter at the end.
3. Compare. Check your lot against the table above or the lists in each section below. A match on the DIN alone does not mean your pen is recalled.
4. Call your pharmacist if it matches. Do this before your next weekly dose. Every notice tells people to speak with a healthcare provider before they stop using the product, or if they have health concerns.^1,2,3,4
5. Report problems. The notices also ask people to report side effects, and any other safety complaint, to Health Canada.^1,3

Can’t find the lot, or threw out the box? Ask the pharmacy that filled your prescription. It can tell you which product and lot it gave you.

Apo-Semaglutide recall RA-82536: 2 mg pen showing a 2 mg dose

This recall covers one lot of the Apo-Semaglutide 2 mg pen: lot 7000599A, DIN 02568020. Pens from that lot may show 2 mg in the dose window and give 2 mg, when the person expected 0.25 mg or 0.5 mg.³

The DIN 02568020 pen holds 2 mg of semaglutide at 0.68 mg/mL and is the Apotex pen for the 0.25 mg and 0.5 mg doses.^5,6 A 2 mg dose is four times a 0.5 mg dose and eight times a 0.25 mg dose.

Health Canada published the notice on August 27, 2026, and lists it as Type II. The recall reaches the retail level, and the recalling firm is Apotex Inc. of Toronto.³

The notice’s change log records a “Lot number correction” on the same day, so if you saw a different lot number in early coverage, use 7000599A.³ The notice does not list the provinces where this lot was sold.

For everything else about this product, including how it compares with Ozempic, see our Apo-Semaglutide guide.

Apo-Semaglutide recall RA-82679: 4 mg pen delivering a lower dose

The second Apotex recall runs the other way. Lot 7000636A of the Apo-Semaglutide 4 mg pen, DIN 02568012, may display 0.25 mg or 0.5 mg in the dose window when the dose should be 1 mg, and it may give that lower amount.⁴

The 4 mg pen is the 1 mg-dose pen, at 1.34 mg/mL.⁵ A pen from this lot could give a quarter or half of the intended dose.

The notice gives a recall date of September 23, 2026, and Health Canada published it on September 25.⁴

This is the only one of the four notices that lists where the lot went. Lot 7000636A was sent to Alberta, B.C., Manitoba, New Brunswick, Newfoundland and Labrador, Ontario and Quebec, and it is a Type II recall at the retail level.⁴

Dr. Reddy’s recall RA-82477: wrong pen in the package

One Dr. Reddy’s lot had the wrong pen in the box. Lot 7000544C, DIN 02567806, came in a box labelled for the 2 mg pen, yet the box held a 4 mg pen.¹

Health Canada published the notice on August 12, 2026, the first of the four. It is Type II, at the retail level, and the recalling firm is Dr. Reddy’s Laboratories Canada Inc. in Mississauga.¹ The notice does not say what dose the mislabelled pen would show or give, and it does not list provinces.

If your box says 2 mg and the pen label says 4 mg, call your pharmacist before your next dose. That check works even if you can’t read the lot.

Dr. Reddy’s recall RA-82537: impurity out of specification

The largest recall covers eight Dr. Reddy’s lots across both of its pens. Health Canada says an impurity was out of specification in the affected lots.²

The lots, exactly as listed on the August 27, 2026 notice:²

• DIN 02567806 (the 0.25 mg or 0.5 mg pen): 7000544, 7000545, 7000546
• DIN 02567814 (the 1 mg pen): 7000542, 7000543, 7000624, 7000628, 7000629

Look closely at lot 7000544. The impurity notice lists it without a letter, while the wrong-pen notice lists 7000544C.^1,2 If your box shows either version, treat it as a match and call your pharmacist.

The notice does not name the impurity or list provinces. It is Type II, at the retail level.²

It came about seven weeks after Dr. Reddy’s reported a shortage of its generic semaglutide, which Alberta Blue Cross dated to July 10, 2026.⁷ Our Dr. Reddy’s semaglutide page covers the shortage and what it means for refills.

What a Type II recall means

A Type II recall is Health Canada’s middle hazard level. It covers products whose use “may cause temporary adverse health consequences”, or where the chance of serious harm is remote.⁸

Health Canada sorts every health product recall into one of three types:^8,9

• Type I: a reasonable probability that use will cause serious harm or death.
• Type II: use may cause temporary health effects, or serious harm is a remote possibility.
• Type III: use is not likely to cause any health effects.

The company, not Health Canada, carries out a recall. Health Canada’s recall policy says the responsible party must assess the risk and assign the type, and Health Canada checks that the type fits the risk.⁹

The policy also says every health product recall is posted in Health Canada’s Recalls and Safety Alerts database.⁹ That database is where all four of these notices live.

The four notices also set the recall depth at “Retailers”.^1,2,3,4 The notices do not explain why that depth was chosen.

Are recalls a sign that generic semaglutide is unsafe?

Not on their own. Brand-name Ozempic has been recalled in Canada too, and these four recalls each name specific lots, which is how the system is meant to catch problems.

Ozempic’s recall, RA-77645, was posted on June 30, 2025, for cracked glass cartridges in two lots under DIN 02471469, and it was also Type II.¹⁰ That was about ten months before the first generic pens went on sale in May 2026.⁵

The more serious semaglutide recall came from outside the authorized supply. In January 2025, Health Canada posted a Type I recall, RA-76830, for semaglutide and pyridoxine syringes and vials from Create Compounding Pharmacy in Calgary.

They had been made with an unauthorized active ingredient and were distributed nationally.¹¹ Type I is the highest hazard level.⁸

Our read: four recalls in the first five months of generic sales is worth watching, and two of them involve dose display, which matters a great deal to the person holding that pen. But each was limited to named lots, rated Type II, and posted publicly.

That is the recall system doing its job. For the usual side effects of semaglutide, recalled lot or not, see our generic semaglutide side effects guide.

Who to contact about a recalled semaglutide pen

Start with your pharmacist, then the company if you still have questions. Each notice tells people to contact the recalling firm with questions and to report side effects to Health Canada.^1,3

• Apo-Semaglutide (RA-82536, RA-82679): the recalling firm is Apotex Inc., based in Toronto.^3,4
• Dr. Reddy’s (RA-82477, RA-82537): the recalling firm is Dr. Reddy’s Laboratories Canada Inc., based in Mississauga, Ontario. The product’s authorization holder is the parent company, Dr. Reddy’s Laboratories Ltd. in India.^1,2

Our read: your pharmacist is still the faster route. The pharmacy handed you the pen, so it is the first place to ask about the lot and a replacement.

Which generic semaglutide pens have no recall?

Most of them. A recall applies to the lots it names, so every other lot of the same product sits outside it.^1,2,3,4

• Apo-Semaglutide: only lot 7000599A of DIN 02568020 and lot 7000636A of DIN 02568012 are recalled. Other Apotex lots are not.^3,4
• Dr. Reddy’s Semaglutide Injection: only the nine lots listed above are recalled, across DINs 02567806 and 02567814.^1,2
• Sevmia, both Aspen products and Sandoz Semaglutide: none of the four notices involves them. On October 22, 2026, the Drug Product Database showed all four as approved but not yet marketed.⁵

How to look up a recall yourself

Health Canada’s recall policy says every health product recall goes into its Recalls and Safety Alerts database.⁹ You can search that database by product name, or by a recall number such as RA-82679, and read the full notice.

Each notice gives the DIN, lot, problem, recall depth and recalling firm. The four notices here also show an original published date and a last-updated date, so you can tell when a notice has changed.^1,2,3,4

Fake and unauthorized semaglutide

A recall only covers authorized products sold through pharmacies. Fake and unauthorized semaglutide is a separate risk, and Health Canada has warned about it directly.

On January 21, 2026, Health Canada issued public advisory RA-81518, warning that retailers in stores and online were selling unauthorized GLP-1 products and that some websites were misusing its logo.¹² Products like these may contain the wrong ingredient or none at all, may be contaminated, or may be injectables that are not sterile.¹²

The advisory’s advice is plain:¹²

• Buy only from a licensed pharmacy.
• Check that the product has an 8-digit DIN, and look it up in Health Canada’s Drug Product Database.
• Treat a seller with no DIN, or a DIN that does not match the product, as a red flag.

Health Canada also said it is seizing unauthorized products and working with the Canada Border Services Agency.¹² For the list of generics that do hold a DIN, see our generic Ozempic guide.

What to do if your semaglutide lot matches a recall

If your lot matches, call your pharmacist before your next dose, keep the pen and the box, and do not stop treatment on your own. Each notice says to talk to a healthcare provider before you stop the product.^1,2,3,4

If your lot does not match, these recalls do not apply to your pen. Each recall is limited to the lots it names.^1,2,3,4

If you have used a pen from a matching lot and feel unwell, or something about your last dose worries you, tell your pharmacist or doctor. The notices also ask people to report side effects to Health Canada.^1,4

Our read: the most useful habit is the cheapest one. When you pick up a new box, glance at the DIN and lot before you leave the counter. If a new recall is posted, it will appear on our news timeline and in the table on this page.